Rankings
▼
Calendar
▼
CYCN Q4 2017 Earnings Report — Cyclerion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Cyclerion Therapeutics, Inc.
CYCN
Q4 2017 Earnings
Reported December 30, 2017
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q4 2017
Q3 2017
Q4 2016
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$28M
-$25M
—
-9.8%
—
EPS (Diluted)
$-20.19
$-18.38
—
-9.8%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$369.0K
GROSS PROFIT
-$369.0K
R&D Expenses
$24M
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$3M
Other Expenses
$0
Operating Expenses
$27M
Cost & Expenses
$28M
OPERATING INCOME
-$28M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$28M
Income Tax Expense
$0
Net Income from Continuing Ops
-$28M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$28M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$28M
D&A
$369.0K
EBIT
-$28M
EBITDA
-$27M
EPS
-$20
EPS Diluted
-$20
marketcaparena.com
← FY 2017
CYCN Overview
Q1 2018 →